Susquehanna International Group
UBX

Susquehanna International Group’s Unity Biotechnology UBX Stock Holding History

Susquehanna International Group’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,700
Closed -$17.4K – 13747
2025
Q1 		$17.4K Buy
+16,700
New +$30.2K ﹤0.01% 12146
2024
Q4 		– Sell
-19,600
Closed -$28.8K – 13269
2024
Q3 		$28.8K Sell
19,600
-8,300
-30% -$12.2K ﹤0.01% 11541
2024
Q2 		$37.7K Buy
+27,900
New +$42.4K ﹤0.01% 11514
2023
Q4 		– Sell
-46,600
Closed -$112K – 13326
2023
Q3 		$112K Sell
46,600
-30,700
-40% -$81.3K ﹤0.01% 10825
2023
Q2 		$197K Buy
+77,300
New +$204K ﹤0.01% 10290
2023
Q1 		– Sell
-380,800
Closed -$1.04M – 13529
2022
Q4 		$1.04M Buy
380,800
+341,720
+874% +$993K ﹤0.01% 6087
2022
Q3 		$156K Buy
39,080
+34,850
+824% +$220K ﹤0.01% 11180
2022
Q2 		$24K Hold
4,230
– – ﹤0.01% 12317
2022
Q1 		$47K Buy
+4,230
New +$47.5K ﹤0.01% 12340
2021
Q4 		– Sell
-1,280
Closed -$38K – 13940
2021
Q3 		$38K Buy
1,280
+220
+21% +$7.76K ﹤0.01% 12434
2021
Q2 		$49K Sell
1,060
-7,790
-88% -$375K ﹤0.01% 12303
2021
Q1 		$531K Buy
8,850
+7,440
+528% +$507K ﹤0.01% 9330
2020
Q4 		$74K Sell
1,410
-4,270
-75% -$206K ﹤0.01% 10625
2020
Q3 		$197K Buy
5,680
+2,800
+97% +$177K ﹤0.01% 9465
2020
Q2 		$250K Buy
2,880
+1,790
+164% +$133K ﹤0.01% 8659
2020
Q1 		$63K Buy
+1,090
New +$68.7K ﹤0.01% 9574

Other funds holding UBX

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

Susquehanna International Group's UBX Position: Q3 2025 in Review

Susquehanna International Group sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 56,720 shares — an estimated $21.6K sold.

Susquehanna International Group first reported a position in UBX in Q4 2018 and held it in 21 quarters. The position peaked at $669K in Q3 2021. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

  • Susquehanna International Group reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 56,720 Unity Biotechnology shares in Q3 2025, an estimated $21.6K.
  • Susquehanna International Group first reported a position in Unity Biotechnology in Q4 2018 and held it in 21 quarters.
  • Susquehanna International Group's Unity Biotechnology position peaked at $669K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.